JP2003128559A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003128559A5 JP2003128559A5 JP2002263431A JP2002263431A JP2003128559A5 JP 2003128559 A5 JP2003128559 A5 JP 2003128559A5 JP 2002263431 A JP2002263431 A JP 2002263431A JP 2002263431 A JP2002263431 A JP 2002263431A JP 2003128559 A5 JP2003128559 A5 JP 2003128559A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic
- disease
- agent according
- decoy
- sequence represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 102000003945 NF-kappa B Human genes 0.000 claims 5
- 108010057466 NF-kappa B Proteins 0.000 claims 5
- 230000001225 therapeutic effect Effects 0.000 claims 5
- 230000000069 prophylactic effect Effects 0.000 claims 4
- 208000023275 Autoimmune disease Diseases 0.000 claims 3
- 208000027866 inflammatory disease Diseases 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010038372 Renal arteriosclerosis Diseases 0.000 claims 1
- 208000033626 Renal failure acute Diseases 0.000 claims 1
- 201000011040 acute kidney failure Diseases 0.000 claims 1
- 208000012998 acute renal failure Diseases 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002263431A JP4159836B2 (ja) | 1995-05-12 | 2002-09-09 | ＮＦ−κＢに起因する疾患の治療および予防剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11499095 | 1995-05-12 | ||
| JP7-114990 | 1995-11-02 | ||
| JP28550495 | 1995-11-02 | ||
| JP7-285504 | 1995-11-02 | ||
| JP2002263431A JP4159836B2 (ja) | 1995-05-12 | 2002-09-09 | ＮＦ−κＢに起因する疾患の治療および予防剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53394796A Division JP3474879B2 (ja) | 1995-05-12 | 1996-05-10 | ＮＦ−κＢに起因する疾患の治療および予防剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003128559A JP2003128559A (ja) | 2003-05-08 |
| JP2003128559A5 true JP2003128559A5 (https=) | 2005-09-29 |
| JP4159836B2 JP4159836B2 (ja) | 2008-10-01 |
Family
ID=27312869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002263431A Expired - Lifetime JP4159836B2 (ja) | 1995-05-12 | 2002-09-09 | ＮＦ−κＢに起因する疾患の治療および予防剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4159836B2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005314381A (ja) * | 2004-03-30 | 2005-11-10 | Anges Mg Inc | 増殖性腎疾患の予防・治療・改善剤 |
| EP1911449A1 (en) | 2005-07-29 | 2008-04-16 | Ltd. Torii Pharmaceutical Co. | Anti-tumor agent comprising 6'-amidino-2'-naphthyl4- guanidinobenzoate or salt thereof |
| WO2013024763A1 (ja) * | 2011-08-12 | 2013-02-21 | 独立行政法人理化学研究所 | 核酸アプタマーの作製方法 |
-
2002
- 2002-09-09 JP JP2002263431A patent/JP4159836B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2213996A1 (en) | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate | |
| CA2306333A1 (en) | Oral morphine multiparticulate formulation | |
| JP2005515407A5 (https=) | ||
| IL210046A0 (en) | Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease | |
| JP2002532112A5 (https=) | ||
| JPH11258809A5 (https=) | ||
| DE60233190D1 (de) | Beschichtung mit verbesserter Deckkraft, daraus hergestellte Zusammensetzungen und Verfahren zu ihrer Herstellung | |
| EP1029540A3 (en) | Use of droloxifene for the treatment of cardiovascular diseases | |
| CN1545409A (zh) | 二苯乙烯类化合物在制备用于治疗和预防糖尿病或与逆转录病毒有关疾病的药物中用途 | |
| JP2002509139A5 (https=) | ||
| PL350786A1 (en) | Cell adhesion−inhibiting antiinflammatory and immune−suppressive compounds | |
| JP2003517386A5 (https=) | ||
| JPH101422A5 (https=) | ||
| JP2005532289A5 (https=) | ||
| DE60004672D1 (de) | Matte pulverbeschichtungszusammensetzung | |
| NO20006113D0 (no) | Anvendelse av cyklosporiner i behandlingen av inflammatoriske autoimmune sykdommer | |
| JP2004532828A5 (https=) | ||
| JP2003128559A5 (https=) | ||
| JP2005509503A5 (https=) | ||
| WO2002072072A3 (fr) | Granules et granules enrobes au gout masque | |
| JP2005524670A5 (https=) | ||
| CA2558429A1 (en) | Compositions and methods for preventing or treating an inflammatory response | |
| FR2847817B1 (fr) | Utilisation d'un inhibiteur d'histone deacetylase pour le traitement des dystrophies musculaires | |
| FR2870082B1 (fr) | Eliminateur d'electricite statique, notamment pour le traitement de polymeres | |
| JP2005529904A5 (https=) |